Health
The company is researching the anti-inflammatory properties of psychedelics to create new drugs with reduced psychoactivity.
Critical research sponsored by the Eleusis Benefit Corporation could lead to new drugs for Alzeimers and Retinal Disease.
The company is developing a technology that seeks to personalize psychedelic therapy experiences for patients.
In this video interview, Orsini describes how he used LSD to help treat his own autism, and what he’s doing to increase awareness for psychedelic-assisted approaches to treating autism.
The benefits of MDMA-assisted psychotherapy appear to grow over time, but the study lacks racial diversity.
The psychiatrist and psychedelics expert Julie Holland discusses why human connection is important for both physical wellbeing and for the body politic in her new book, Good Chemistry.
Research reveals how DMT affects brain waves to give rise to visionary experiences.
The Oregon-based startup is taking applications from healthcare workers to receive psychedelic-assisted therapy at a Jamaican retreat center. Will they be ready?
Scientists get closer to understanding why psychedelics show promise for treating mental illness.
SLC Ketamine claims longer lasting benefits from its approach, while offering free treatments to veterans.
